001     281370
005     20251012002045.0
024 7 _ |a 10.1016/j.isci.2025.113435
|2 doi
024 7 _ |a altmetric:180730753
|2 altmetric
024 7 _ |a pmid:41054519
|2 pmid
037 _ _ |a DZNE-2025-01117
082 _ _ |a 050
100 1 _ |a Kroon, Cristina
|b 0
245 _ _ |a Phosphorylation of presynaptic PLPPR3 controls synaptic vesicle release
260 _ _ |a St. Louis
|c 2025
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1759836611_17317
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Phospholipid-phosphatase-related protein 3 (PLPPR3) belongs to a family of transmembrane proteins highly expressed in the nervous system where it regulates critical axonal growth processes during guidance, filopodia formation, and branching. However, little is known regarding its role in synapses and the signaling events regulating PLPPR3 function. Here, we identify 26 high-confidence phosphorylation sites in the intracellular domain of PLPPR3 using mass spectrometry. Biochemical characterization established one of these—S351—as a bona fide phosphorylation site of protein kinase A (PKA). PLPPR3 is enriched at presynaptic terminals, and deletion of PLPPR3 results in increased depolarization-induced synaptic vesicle release in hippocampal neurons. This tonic inhibitory signal toward depolarization-induced presynaptic activity is corrected by expression of PLPPR3 intracellular domain, but not a S351A phospho-dead mutant, in Plppr3−/− hippocampal neurons. We propose that PLPPR3 phosphorylation under the control of PKA activity is a signaling integrator of presynaptic activity in hippocampal neurons.
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: pub.dzne.de
700 1 _ |a Bareesel, Shannon
|b 1
700 1 _ |a Perez, Gerard Aguilar
|0 P:(DE-2719)9002012
|b 2
|u dzne
700 1 _ |a Nagy-Herczeg, Domonkos
|b 3
700 1 _ |a Ranti, Dimitra
|b 4
700 1 _ |a Syropoulou, Vasiliki
|b 5
700 1 _ |a Coveney, Sandra
|b 6
700 1 _ |a Kirchner, Marieluise
|b 7
700 1 _ |a Gimber, Niclas
|b 8
700 1 _ |a Bintig, Willem
|b 9
700 1 _ |a Brosig, Annika
|b 10
700 1 _ |a Braune, Georg
|b 11
700 1 _ |a Textoris-Taube, Kathrin
|b 12
700 1 _ |a Zolnik, Timothy A.
|b 13
700 1 _ |a Mertins, Philipp
|b 14
700 1 _ |a Schmoranzer, Jan
|b 15
700 1 _ |a Milovanovic, Dragomir
|0 P:(DE-2719)9000670
|b 16
|u dzne
700 1 _ |a Leondaritis, George
|b 17
700 1 _ |a Eickholt, Britta J.
|0 0000-0001-7873-8687
|b 18
773 _ _ |a 10.1016/j.isci.2025.113435
|g Vol. 28, no. 9, p. 113435 -
|0 PERI:(DE-600)2927064-9
|n 9
|p 113435
|t iScience
|v 28
|y 2025
|x 2589-0042
856 4 _ |u https://pub.dzne.de/record/281370/files/DZNE-2025-01117%20SUP.pdf
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/281370/files/DZNE-2025-01117.pdf
856 4 _ |x pdfa
|u https://pub.dzne.de/record/281370/files/DZNE-2025-01117%20SUP.pdf?subformat=pdfa
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/281370/files/DZNE-2025-01117.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:281370
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9002012
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 16
|6 P:(DE-2719)9000670
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-02
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ISCIENCE : 2022
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-04-12T14:51:15Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-04-12T14:51:15Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-02
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-02
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-04-12T14:51:15Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-01-02
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b ISCIENCE : 2022
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-02
920 1 _ |0 I:(DE-2719)1813002
|k AG Milovanovic (Berlin)
|l Molecular Neuroscience
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1813002
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21